Elevance Health Retained Earnings (Accumulated Deficit) 2010-2025 | ELV
Elevance Health retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Elevance Health retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $34.546B, a 4.41% increase year-over-year.
- Elevance Health retained earnings (accumulated deficit) for 2024 were $33.549B, a 5.67% increase from 2023.
- Elevance Health retained earnings (accumulated deficit) for 2023 were $31.749B, a 7.09% increase from 2022.
- Elevance Health retained earnings (accumulated deficit) for 2022 were $29.647B, a 9.45% increase from 2021.
| Elevance Health Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $33,549 |
| 2023 | $31,749 |
| 2022 | $29,647 |
| 2021 | $27,088 |
| 2020 | $23,802 |
| 2019 | $22,573 |
| 2018 | $19,988 |
| 2017 | $18,054 |
| 2016 | $16,561 |
| 2015 | $14,779 |
| 2014 | $14,014 |
| 2013 | $13,814 |
| 2012 | $12,647 |
| 2011 | $11,491 |
| 2010 | $10,722 |
| 2009 | $9,599 |
| Elevance Health Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $34,546 |
| 2024-12-31 | $33,549 |
| 2024-09-30 | $35,157 |
| 2024-06-30 | $34,575 |
| 2024-03-31 | $33,088 |
| 2023-12-31 | $31,749 |
| 2023-09-30 | $32,103 |
| 2023-06-30 | $31,608 |
| 2023-03-31 | $30,707 |
| 2022-12-31 | $29,647 |
| 2022-09-30 | $29,604 |
| 2022-06-30 | $28,825 |
| 2022-03-31 | $28,058 |
| 2021-12-31 | $27,088 |
| 2021-09-30 | $26,700 |
| 2021-06-30 | $25,874 |
| 2021-03-31 | $24,793 |
| 2020-12-31 | $23,802 |
| 2020-09-30 | $24,678 |
| 2020-06-30 | $25,346 |
| 2020-03-31 | $23,360 |
| 2019-12-31 | $22,573 |
| 2019-09-30 | $22,104 |
| 2019-06-30 | $21,679 |
| 2019-03-31 | $21,136 |
| 2018-12-31 | $19,988 |
| 2018-09-30 | $20,182 |
| 2018-06-30 | $19,757 |
| 2018-03-31 | $19,241 |
| 2017-12-31 | $18,054 |
| 2017-09-30 | $17,307 |
| 2017-06-30 | $17,667 |
| 2017-03-31 | $17,358 |
| 2016-12-31 | $16,561 |
| 2016-09-30 | $16,364 |
| 2016-06-30 | $15,918 |
| 2016-03-31 | $15,310 |
| 2015-12-31 | $14,779 |
| 2015-09-30 | $14,762 |
| 2015-06-30 | $14,352 |
| 2015-03-31 | $14,150 |
| 2014-12-31 | $14,014 |
| 2014-09-30 | $13,864 |
| 2014-06-30 | $13,744 |
| 2014-03-31 | $14,012 |
| 2013-12-31 | $13,814 |
| 2013-09-30 | $14,041 |
| 2013-06-30 | $13,818 |
| 2013-03-31 | $13,275 |
| 2012-12-31 | $12,647 |
| 2012-09-30 | $12,557 |
| 2012-06-30 | $12,224 |
| 2012-03-31 | $11,921 |
| 2011-12-31 | $11,491 |
| 2011-09-30 | $11,573 |
| 2011-06-30 | $11,418 |
| 2011-03-31 | $11,200 |
| 2010-12-31 | $10,722 |
| 2010-09-30 | $10,582 |
| 2010-06-30 | $9,998 |
| 2010-03-31 | $9,796 |
| 2009-12-31 | $9,599 |
| 2009-09-30 | $7,127 |
| 2009-06-30 | $6,640 |
| 2009-03-31 | $5,971 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $84.931B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.155B | 26.10 |
| CVS Health (CVS) | United States | $84.554B | 10.51 |
| Cencora (COR) | United States | $57.517B | 20.01 |
| Natera (NTRA) | United States | $23.347B | 0.00 |
| DiDi Global (DIDIY) | China | $22.403B | 23.80 |
| Labcorp Holdings (LH) | United States | $21.878B | 17.75 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.676B | 0.00 |
| Solventum (SOLV) | United States | $12.566B | 13.30 |
| CochLear (CHEOY) | Australia | $12.083B | 0.00 |
| ICON (ICLR) | Ireland | $11.595B | 10.78 |
| Revvity (RVTY) | United States | $11.128B | 19.15 |
| Doximity (DOCS) | United States | $10.714B | 49.60 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| HealthEquity (HQY) | United States | $8.820B | 38.64 |
| Medpace Holdings (MEDP) | United States | $8.700B | 23.11 |
| Sonic Healthcare (SKHHY) | Australia | $8.407B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.136B | 13.98 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.085B | 24.06 |
| BrightSpring Health Services (BTSG) | United States | $3.934B | 36.10 |
| Sotera Health (SHC) | United States | $3.105B | 17.65 |
| Alignment Healthcare (ALHC) | United States | $2.849B | 0.00 |
| Concentras Parent (CON) | United States | $2.676B | 15.47 |
| Organon (OGN) | United States | $2.568B | 2.73 |
| Surgery Partners (SGRY) | United States | $2.542B | 33.06 |
| PACS (PACS) | United States | $2.027B | 0.00 |
| Progyny (PGNY) | United States | $1.856B | 40.85 |
| Ardent Health (ARDT) | United States | $1.854B | 7.90 |
| GeneDx Holdings (WGS) | United States | $1.838B | 70.80 |
| Premier (PINC) | United States | $1.834B | 13.92 |
| GoodRx Holdings (GDRX) | United States | $1.600B | 32.00 |
| Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.147B | 8.73 |
| Establishment Labs Holdings (ESTA) | $1.100B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.55 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.856B | 8.01 |
| QDM (QDMI) | Hong Kong, SAR China | $0.758B | 0.00 |
| LifeMD (LFMD) | United States | $0.684B | 0.00 |
| Nutex Health (NUTX) | United States | $0.661B | 10.01 |
| Embecta (EMBC) | United States | $0.569B | 3.83 |
| InnovAge Holding (INNV) | United States | $0.512B | 0.00 |
| SBC Medicals (SBC) | United States | $0.482B | 0.00 |
| Enhabit (EHAB) | United States | $0.473B | 38.92 |
| Auna S.A (AUNA) | Luxembourg | $0.459B | 10.33 |
| Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.449B | 0.00 |
| Omada Health (OMDA) | $0.399B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.267B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.165B | 27.00 |
| Pheton Holdings (PTHL) | China | $0.119B | 0.00 |
| So-Young (SY) | China | $0.102B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.052B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |